← All diseases
Cancer
Bladder cancer
Would you like to receive a message when there is new research about Bladder Cancer? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above every publication you'll find one sentence explaining what was studied — and you'll be notified as soon as there's new research on Bladder cancer. View what Premium costs.
Publications and studies (2674)
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Robot-Assisted Radical Cystectomy: Recommendations from Latin American Experts Consensus on Surgical Strategy, Urinary Reconstruction, and Oncological and Func-tional Outcomes. (2026/11/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The impact of cachexia and sarcopenia in bladder cancer. (2026/09/01) ♡
- The significance of vascular endothelial growth factor and systemic inflammatory reaction in bladder cancer patients. (2026/09/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Radiomic phenotypes in nonmuscle-invasive bladder cancer: A precision biomarker guiding therapy. (2026/08/15) ♡
- Bladder mucosal afferents detect UTI and aid pathogen clearance. (2026/08/11) ♡
- KLF6-driven macrophage-to-myofibroblast transition promotes PD-L1-mediated immune evasion in bladder cancer. (2026/08/10) ♡
- Integration of a multimeric STAT consensus site into the adenoviral genome to interfere with IFN signaling represents a novel concept to improve oncolytic virotherapy. (2026/08/10) ♡
- Deletion of the Salmonella pathogenicity island 2 gene, spiC, in attenuated Salmonella Typhimurium VNP20009 optimizes its potential for bacterial schwannoma therapy. (2026/08/10) ♡
- Hybrid grading systems improve progression risk stratification in non-invasive papillary urothelial carcinoma and support a histomorphological continuum of disease progression. (2026/08/10) ♡
- Optimal bladder cuff management in radical nephroureterectomy: A multicenter retrospective cohort study comparing one-position excision versus ureteral pluck technique. (2026/08/08) ♡
- Hemostatic Efficacy and Clinical Outcomes of Radiotherapy in Older Adult Patients With Advanced Bladder Cancer and Hematuria Unsuitable for Standard Treatment. (2026/08/08) ♡
- Comparison of postoperative and early oncological outcomes of open versus robotic radical cystectomy. (2026/08/08) ♡
- Biophysical reprogramming of immunosuppressive neutrophils by cold atmospheric plasma reinvigorates antitumor immunity. (2026/08/07) ♡
- Assembly-formed bioorthogonal chimeric artificial receptors enable high-contrast fluorescence imaging of tumors. (2026/08/07) ♡
- Health Care Utilization and Costs Associated With Blue-Light vs White-Light Cystoscopy: A Real-World Bladder Cancer Population. (2026/08/07) ♡
- Synthesis of ACT-007 and Its Analogues with Antiproliferative Activity. (2026/08/07) ♡
- Prognostic significance of non-muscle-invasive late recurrence after intravesical bacillus Calmette-Guérin therapy in bladder cancer: a multicenter, retrospective real-world study (the Japan Urological Oncology Group). (2026/08/07) ♡
- Multifocal primary hepatic epithelioid hemangioendothelioma: a case in which tumor biopsy was critical to prevent misdiagnosis. (2026/08/07) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Intracorporeal urinary diversion during robot-assisted radical cystectomy: a bibliometric and visualization analysis of research evolution, evidence landscape, learning curves, and clinical outcomes. (2026/08/07) ♡
- NeoBLAST: A Pilot Randomized Controlled Trial of Active Surveillance Versus Definitive Bladder Treatment Following Clinical Complete Response to Neoadjuvant Therapy in Muscle-invasive Bladder Cancer - Study Protocol. (2026/08/07) ♡
- Prognostic Factors After Radical Cystectomy for Non-muscle-invasive Bladder Cancer: From Prognostication to Patient Selection. (2026/08/07) ♡
- Urinary volatilomics using liquid-liquid extraction and gas chromatography-mass spectrometry (GC-MS) combined with machine learning algorithms as a tool for diagnosis and surveillance of urothelial bladder cancer. (2026/08/07) ♡
- NPTXR as a novel therapeutic target: efficacy of antibody-drug conjugates in preclinical tumor models. (2026/08/07) ♡
- Transurethral prostate resection with high-intensity focused ultrasound achieves a superior functional outcome in prostate cancer patients. (2026/08/06) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Calibrated dietary patterns and cancer risk in the women's health initiative cohorts. (2026/08/05) ♡
- LAMC2(+) Epithelial Cells Drive Bladder Cancer Progression and Predict Immunotherapy Response via SERPINB3/STAT3/CD44 Axis. (2026/08/05) ♡
- Staphylococcus aureus urease is controlled by a complex regulatory network to promote dissemination during CAUTI. (2026/08/05) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Recombinant BCG-Ag85A enhances antitumor immunity and controls melanoma progression through multimodal immune activation in mice. (2026/08/05) ♡
- Integrated Immunological Analysis of Interactions Between CXCL13+ T Cells and LAMP3+ DC in the Immunotherapy Response of Bladder Cancer. (2026/08/05) ♡
- Decoupling the dosimetric impact of setup errors and anatomical deformations in image-guided radiotherapy using diagnostic-quality FBCT and glmmLasso regularization. (2026/08/05) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Bacillus Calmette-Guérin (BCG) with or without immune checkpoint blockade in BCG-naïve high-risk non-muscle-invasive bladder cancer: A systematic review and reconstructed individual patient data meta-analysis. (2026/08/05) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Urinary Biomarkers for Cancer Diagnosis and Surveillance: From Analytical Promise to Clinical Utility. (2026/08/05) ♡
- Conceptualizing the "High" Bladder Neck - Anatomic Rabbit Hole or Functional Gold Mine? (2026/08/05) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Response evaluation of neoadjuvant therapy in MIBC: clinical trial-derived evidence to guide practice. (2026/08/05) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Integrating clinically actionable biomarkers into bladder cancer care - recommendations from the International Bladder Cancer Group. (2026/08/05) ♡
- Online adaptive radiotherapy in pelvic and thoracic cancers - comparing toxicities, clinical outcomes and technical parameters between conventional image-guided radiotherapy and online adaptive radiotherapy - the study protocol for the prospective, registry-based cohort study (PRoART). (2026/08/05) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Presumed Simultaneous Intraocular and Extraocular BCG-osis as a Complication of Intravesical Bacillus Calmette-Guérin Treatment for Non-Muscle-Invasive Bladder Cancer: A Case Report. (2026/08/05) ♡
- Lifestyle and dietary inflammation scores and risks of recurrence and progression among patients with non-muscle invasive bladder cancer. (2026/08/05) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Validation of an AI-based Histologic Prognostic Biomarker in Patients with Non-muscle-invasive Bladder Cancer Using the Prospective Swedish National Register of Urinary Bladder Cancer. (2026/08/04) ♡
- Integrative Genomic Analysis Reveals Molecular and Clinical Disparities between Bladder and Upper Tract Urothelial Carcinoma in K-MASTER Program. (2026/08/04) ♡
- Editor's Note: Cis-dichlorodiammineplatinum Upregulates Angiotensin II Type 1 Receptors through Reactive Oxygen Species Generation and Enhances VEGF Production in Bladder Cancer. (2026/08/04) ♡
- The Prevalence of the AR-V7 variant and its Association with Clinicopathologic Characteristics in Non-prostatic Cancers - A Systematic Review. (2026/08/04) ♡
- Circ_0001495 promotes bladder cancer progression by regulating miR-1184 via MAPK signaling pathway. (2026/08/04) ♡
- ASO Visual Abstract: Preoperative Tumor-Informed ctDNA for Prediction of Nodal Metastases at Radical Cystectomy in Bladder Cancer. (2026/08/04) ♡
- Complete Response to Intravesical BCG for High-Risk pT1 Bladder Cancer With Lymphovascular Invasion: A Case Report. (2026/08/04) ♡
- Comparison of Sex-Specific Treatment Outcomes in Clinical Trials and Subsequent Real-World Data on Systemic Therapies for Urothelial Carcinoma: A Systematic Review. (2026/08/04) ♡
- FGFR3-driven gene regulatory network analysis reveals a protumoral role for p63 in luminal bladder tumors. (2026/08/03) ♡
- UCtracker: A Deep Learning-Based DNA Methylation Model for Noninvasive Diagnosis and Recurrence Surveillance of Urothelial Carcinoma in a Prospective Study. (2026/08/03) ♡
- Intermediate rectal dose is associated with late toxicity after prostate SBRT: a dose-volume histogram principal component analysis. (2026/08/03) ♡
- Prognostic value of different biomarkers in bladder cancer: protocol for an umbrella review of systematic reviews and meta-analyses. (2026/08/03) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.